These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19747571)

  • 1. Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations.
    Willey JS; Livingston EW; Robbins ME; Bourland JD; Tirado-Lee L; Smith-Sielicki H; Bateman TA
    Bone; 2010 Jan; 46(1):101-11. PubMed ID: 19747571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zordan S; Sella S; Fassina A; Turco G; Realdi G; Lo Cascio V; Giannini S
    J Endocrinol Invest; 2007 Oct; 30(9):739-46. PubMed ID: 17993765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
    Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
    Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.
    Sugiyama T; Meakin LB; Galea GL; Jackson BF; Lanyon LE; Ebetino FH; Russell RG; Price JS
    Bone; 2011 Jul; 49(1):133-9. PubMed ID: 21497678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal effects of constant and terminated use of risedronate on cortical bone in ovariectomized rats.
    Li QN; Liang NC; Huang LF; Wu T; Hu B; Mo LE
    J Bone Miner Metab; 1999; 17(1):18-22. PubMed ID: 10084397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures.
    Geoffroy V; Paschalis EP; Libouban H; Blouin S; Ostertag A; Chappard D; Cros M; Phipps R; de Vernejoul MC
    Calcif Tissue Int; 2011 Jun; 88(6):464-75. PubMed ID: 21455736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats.
    Mosekilde L; Thomsen JS; Mackey MS; Phipps RJ
    Bone; 2000 Nov; 27(5):639-45. PubMed ID: 11062350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry study.
    Iwamoto J; Matsumoto H; Tadeda T; Sato Y; Yeh JK
    Yonsei Med J; 2009 Apr; 50(2):189-94. PubMed ID: 19430549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
    Iwamoto J; Takeda T; Sato Y; Yeh JK
    Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):21-7. PubMed ID: 16637226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse.
    Yang Li C; Majeska RJ; Laudier DM; Mann R; Schaffler MB
    Bone; 2005 Sep; 37(3):287-95. PubMed ID: 16006205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model.
    Nam SH; Jeong JH; Che X; Lim KE; Nam H; Park JS; Choi JY
    Bone; 2012 Jan; 50(1):149-55. PubMed ID: 22036912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss.
    Kwak HB; Kim JY; Kim KJ; Choi MK; Kim JJ; Kim KM; Shin YI; Lee MS; Kim HS; Kim JW; Chun CH; Cho HJ; Hong GY; Juhng SK; Yoon KH; Park BH; Bae JM; Han JK; Oh J
    Biol Pharm Bull; 2009 Jul; 32(7):1193-8. PubMed ID: 19571384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
    Borah B; Dufresne TE; Chmielewski PA; Johnson TD; Chines A; Manhart MD
    Bone; 2004 Apr; 34(4):736-46. PubMed ID: 15050906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.
    Fuchs RK; Phipps RJ; Burr DB
    J Bone Miner Res; 2008 Oct; 23(10):1689-97. PubMed ID: 18466070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
    Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
    Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.
    Shiraishi A; Miyabe S; Nakano T; Umakoshi Y; Ito M; Mihara M
    BMC Musculoskelet Disord; 2009 Jun; 10():66. PubMed ID: 19527501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
    J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.